In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)
about
Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping dataSoluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and agingTRPM8 and Nav1.8 sodium channels are required for transthyretin-induced calcium influx in growth cones of small-diameter TrkA-positive sensory neurons.Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway.Protein folding and aggregation into amyloid: the interference by natural phenolic compoundsIs RAGE still a therapeutic target for Alzheimer's disease?Solution structure of the soluble receptor for advanced glycation end products (sRAGE).The S100B/RAGE Axis in Alzheimer's Disease.Protein folding and misfolding on surfaces.Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.
P2860
Q33399896-B47C36A8-E912-4F12-9004-98F86AD221C6Q34094369-71280BFA-6D1B-4612-9F7F-655400456F05Q34677515-350E7ADC-93FF-4E56-B47C-B828B0C422B0Q35901035-D127A846-EDE4-443E-8287-C7637B6D1F23Q36321887-254C6C10-F170-4B62-A92B-895F9C289F0BQ37007345-8918C368-BB86-4D52-BBFE-FF588F778872Q38008724-A79EE53F-A5C4-4C17-A797-0550F1785E15Q38795678-CCCB3A69-C069-4C3F-8E7F-D6C314E91922Q42151789-1ADA99CC-E042-4F21-9DFF-17024B0AB7ACQ43187852-C4A07955-A229-4821-8CBA-3421633E01F0Q47404960-E81E2AC9-3D59-4492-B4C5-14B8D116CA15Q47865490-894C6F65-44EC-467E-83FA-9986B803FEA5Q50485049-7BB07648-93D7-46D9-8B5A-3540CDB869E6Q52583445-A2B2A4BF-4CF6-4AA9-ADCB-D36E6B18C975
P2860
In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vitro inhibition of transth ...... glycation end products (RAGE)
@ast
In vitro inhibition of transth ...... glycation end products (RAGE)
@en
In vitro inhibition of transth ...... glycation end products (RAGE)
@en-gb
In vitro inhibition of transth ...... glycation end products (RAGE)
@nl
type
label
In vitro inhibition of transth ...... glycation end products (RAGE)
@ast
In vitro inhibition of transth ...... glycation end products (RAGE)
@en
In vitro inhibition of transth ...... glycation end products (RAGE)
@en-gb
In vitro inhibition of transth ...... glycation end products (RAGE)
@nl
prefLabel
In vitro inhibition of transth ...... glycation end products (RAGE)
@ast
In vitro inhibition of transth ...... glycation end products (RAGE)
@en
In vitro inhibition of transth ...... glycation end products (RAGE)
@en-gb
In vitro inhibition of transth ...... glycation end products (RAGE)
@nl
P2860
P50
P1433
P1476
In vitro inhibition of transth ...... glycation end products (RAGE)
@en
P2860
P304
P356
10.1016/J.FEBSLET.2006.05.020
P407
P577
2006-06-12T00:00:00Z